Literature DB >> 24726207

HPV and head and neck cancers: state-of-the-science.

Carole Fakhry1, Amanda Psyrri2, Anil Chaturvedhi3.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24726207     DOI： 10.1016/j.oraloncology.2014.03.010

Source DB:  PubMed          Journal:  Oral Oncol        ISSN： 1368-8375            Impact factor:   5.337


× No keyword cloud information.
  14 in total

1.  Pre-therapeutic fibrinogen levels are of prognostic significance in locally advanced head and neck cancer.

Authors:  Edgar Selzer; Anja Grah; Gregor Heiduschka; Gabriela Kornek; Dietmar Thurnher
Journal:  Wien Klin Wochenschr       Date:  2016-02-26       Impact factor: 1.704

2.  Oncolytic adenoviruses targeted to Human Papilloma Virus-positive head and neck squamous cell carcinomas.

Authors:  Christopher J LaRocca; Joohee Han; Amanda O Salzwedel; Julia Davydova; Mark C Herzberg; Rajaram Gopalakrishnan; Masato Yamamoto
Journal:  Oral Oncol       Date:  2016-03-18       Impact factor: 5.337

3.  Immunometabolic Alterations by HPV Infection: New Dimensions to Head and Neck Cancer Disparity.

Authors:  Sanjib Chaudhary; Koelina Ganguly; Sakthivel Muniyan; Ramesh Pothuraju; Zafar Sayed; Dwight T Jones; Surinder K Batra; Muzafar A Macha
Journal:  J Natl Cancer Inst       Date:  2019-03-01       Impact factor: 13.506

4.  Human papillomavirus in oropharyngeal squamous cell carcinoma in South-Eastern Norway: prevalence, genotype, and survival.

Authors:  Guro Haugen Fossum; Agnes Kathrine Lie; Peter Jebsen; Lars Erik Sandlie; Jon Mork
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-09-20       Impact factor: 2.503

5.  Intra-cheek immunization as a novel vaccination route for therapeutic vaccines of head and neck squamous cell carcinomas using plasmo virus-like particles.

Authors:  Rodney Macedo; Juliette Rochefort; Maude Guillot-Delost; Kae Tanaka; Aline Le Moignic; Clara Noizat; Claude Baillou; Véronique Mateo; Antoine F Carpentier; Eric Tartour; Chloé Bertolus; Bertrand Bellier; Géraldine Lescaille; François M Lemoine
Journal:  Oncoimmunology       Date:  2016-07-06       Impact factor: 8.110

6.  Coinfection with Epstein-Barr Virus (EBV), Human Papilloma Virus (HPV) and Polyoma BK Virus (BKPyV) in Laryngeal, Oropharyngeal and Oral Cavity Cancer.

Authors:  Bartłomiej Drop; Małgorzata Strycharz-Dudziak; Ewa Kliszczewska; Małgorzata Polz-Dacewicz
Journal:  Int J Mol Sci       Date:  2017-12-19       Impact factor: 5.923

7.  Associations of Oral α-, β-, and γ-Human Papillomavirus Types With Risk of Incident Head and Neck Cancer.

Authors:  Ilir Agalliu; Susan Gapstur; Zigui Chen; Tao Wang; Rebecca L Anderson; Lauren Teras; Aimée R Kreimer; Richard B Hayes; Neal D Freedman; Robert D Burk
Journal:  JAMA Oncol       Date:  2016-05-01       Impact factor: 31.777

8.  Divergent viral presentation among human tumors and adjacent normal tissues.

Authors:  Song Cao; Michael C Wendl; Matthew A Wyczalkowski; Kristine Wylie; Kai Ye; Reyka Jayasinghe; Mingchao Xie; Song Wu; Beifang Niu; Robert Grubb; Kimberly J Johnson; Hiram Gay; Ken Chen; Janet S Rader; John F Dipersio; Feng Chen; Li Ding
Journal:  Sci Rep       Date:  2016-06-24       Impact factor: 4.379

9.  The rationale for HPV-related oropharyngeal cancer de-escalation treatment strategies.

Authors:  Małgorzata Wierzbicka; Krzysztof Szyfter; Piotr Milecki; Krzysztof Składowski; Rodryg Ramlau
Journal:  Contemp Oncol (Pozn)       Date:  2015-09-28

Review 10.  uPA/uPAR and SERPINE1 in head and neck cancer: role in tumor resistance, metastasis, prognosis and therapy.

Authors:  Miguel Angel Pavón; Irene Arroyo-Solera; Maria Virtudes Céspedes; Isolda Casanova; Xavier León; Ramón Mangues
Journal:  Oncotarget       Date:  2016-08-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.